慢病毒介導(dǎo)hVEGF-165基因轉(zhuǎn)染骨髓間充質(zhì)干細(xì)胞治療大鼠后肢缺血實(shí)驗(yàn)研究
[Abstract]:Aim: to investigate the therapeutic effect of bone marrow mesenchymal stem cells carrying human vascular endothelial growth factor-165 gene on hindlimb ischemia in rats. Methods: three experimental groups were set up in this experiment. They were hVEGF-165 gene transfected BMSC group and blank control group. There were 8 effective samples in each group with 48 limbs in each group. The ischemia model was established by ligating the abdominal aortic bifurcation of SD rats. The blood flow velocity and resistance of femoral artery were measured and identified by observing DSA angiography after operation. The hVEGF-165 gene was transfected into rat bone marrow mesenchymal stem cells (BMSCs) by lentivirus-mediated transfection with GFP fluorescent protein. The transfection rate of hVEGF-165 gene was detected by fluorescence microscope. The stem cells with 1X106/ml concentration were transplanted into ischemic limbs by multi-point injection of rat hindlimb muscle. One month later, the blood flow velocity and resistance of femoral artery were measured by observing DSA angiography. Results under the fluorescence microscope, the positive rate of lentivirus mediated hVEGF-165 gene transfection BMSCs was over 85%. The ischemic model was made by ligation of abdominal aorta. 30 days after operation, all rats showed claudication and toe necrosis. Most rats had ischemic ulcers in their limbs. Color Doppler ultrasound, hindlimb angiography and other examinations showed that the blood flow of the hind limb of the experimental rats after ligation was significantly decreased, the resistance index was significantly decreased, the blood vessel density was significantly decreased by 0.3, the curative effect was detected 30 days after transplantation, and the blood flow velocity of the hind limb of the rats was measured. The resistance index and microvessel density in BMSC group were significantly higher than those in control group, while those in transgenic BMSC group were higher than those in BMSC group (p0.01). Conclusion: the positive rate of hVEGF-165 gene transfection with lentivirus vector is high, and the ischemic effect of hind limb ischemia model made by ligation above the abdominal aorta bifurcation of SD rats is obvious and lasting for a long time. BMSCs, carrying hVEGF-165 gene could improve the blood supply of hind limb after ischemia, but transfection of hVEGF165 gene BMSCs had more advantages in promoting angiogenesis.
【學(xué)位授予單位】:遵義醫(yī)學(xué)院
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2011
【分類號(hào)】:R329
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 張從紀(jì);楊彥春;單佑安;;VEGF基因真核表達(dá)載體的構(gòu)建及其在骨髓間充質(zhì)干細(xì)胞中的表達(dá)[J];重慶醫(yī)學(xué);2010年01期
2 鄭巖;易成剛;郭樹忠;劉丹;黃博;夏煒;潘華;隋繼強(qiáng);;VEGF基因體外轉(zhuǎn)染大鼠骨髓間充質(zhì)干細(xì)胞的實(shí)驗(yàn)研究[J];中國美容醫(yī)學(xué);2006年09期
3 梁翠宏;田鏵;徐蘊(yùn);李貴寶;田廣平;宋濤;;結(jié)扎切斷法與白芨微粒栓塞法建立大鼠后肢缺血模型效果比較[J];山東大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2007年10期
4 溫銘杰;劉冰;孫麗翠;祁雅慧;;人VEGF_(165)和bFGF基因聯(lián)合治療大鼠急性心肌梗死[J];首都醫(yī)科大學(xué)學(xué)報(bào);2006年05期
5 毛穎佳;鄭源強(qiáng);石艷春;;慢病毒載體及其應(yīng)用的研究進(jìn)展[J];中國生物制品學(xué)雜志;2009年02期
6 田力;田曉曄;范妮娜;梁曉鵬;于鑫琛;;VEGF-165基因修飾的MSCs誘導(dǎo)分化后治療兔股骨頭缺血性壞死的實(shí)驗(yàn)研究[J];沈陽醫(yī)學(xué)院學(xué)報(bào);2009年03期
7 周文武;高紀(jì)平;李梨平;;轉(zhuǎn)染血管內(nèi)皮細(xì)胞生長因子基因骨髓間充質(zhì)干細(xì)胞移植對(duì)大鼠心肌梗死區(qū)血管新生的影響(英文)[J];中國組織工程研究與臨床康復(fù);2008年25期
8 叢林;趙玉沛;陳革;張?zhí)?周皎琳;廖泉;;轉(zhuǎn)染人VEGF165基因?qū)Υ笫笠葝u移植物再血管化及生物學(xué)功能的影響[J];中華器官移植雜志;2006年07期
9 杜建時(shí);趙晴;張英麗;陳珂;;血管內(nèi)皮生長因子對(duì)骨髓間充質(zhì)干細(xì)胞分離培養(yǎng)的誘導(dǎo)分化作用[J];中國老年學(xué)雜志;2007年13期
10 谷涌泉;張建;齊立行;郭連瑞;張淑文;廖傳軍;李建新;俞恒錫;李學(xué)鋒;崔世軍;羅濤;楊盛家;陳兵;汪忠鎬;;不同移植濃度自體骨髓干細(xì)胞治療下肢缺血臨床療效的影響[J];中國修復(fù)重建外科雜志;2006年05期
,本文編號(hào):2201594
本文鏈接:http://sikaile.net/xiyixuelunwen/2201594.html